Large HDL2 combined with inflammatory factors as superior predictors for coronary artery disease than small HDL3

Xiaoying Wu1, Zhijian He2, Runlu Sun1

  • 1Cardiovascular Medicine Department, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Insights

High-density lipoprotein (HDL) subfraction HDL2, along with inflammatory markers monocyte chemoattractant protein-1 (MCP-1) and high-sensitivity C-reactive protein (hsCRP), significantly improves coronary artery disease (CAD) prediction when combined with conventional risk factors.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Preventive Cardiology

Background:

  • Coronary artery disease (CAD) prediction relies on conventional risk factors (CRFs).
  • The added value of high-density lipoprotein (HDL) subfractions and inflammatory markers to CAD risk stratification requires further investigation.

Purpose of the Study:

  • To determine if combinations of HDL subfractions and inflammatory markers enhance CAD prediction beyond CRFs.
  • To compare the predictive value of different HDL subfractions (HDL2, HDL3) and inflammatory markers (MCP-1, hsCRP) in CAD risk assessment.

Main Methods:

  • Stratified 245 non-CAD subjects into low/moderate/high-Framingham risk (L/M/H-FR) groups and enrolled 180 CAD patients.
  • Measured levels of HDL-C, HDL2, HDL3, monocyte chemoattractant protein-1 (MCP-1), and high-sensitivity C-reactive protein (hsCRP).
  • Utilized multivariable logistic regression, Z statistics, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) to compare model discrimination after adjusting for CRFs.

Main Results:

  • HDL2 and HDL-C levels decreased, while MCP-1 and hsCRP increased from low to high risk groups.
  • HDL2 was the only significant HDL subfraction associated with CAD risk when all HDL parameters were considered.
  • A combined model including HDL2, MCP-1, and hsCRP significantly improved CAD prediction (NRI=0.179, IDI=0.081, P<0.001) compared to models with single factors or all HDL parameters.

Conclusions:

  • Larger HDL2 subfractions demonstrate a stronger inverse association with CAD risk than smaller HDL3 subfractions.
  • The combination of HDL2, MCP-1, and hsCRP with CRFs offers an optimal predictive model for coronary artery disease.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
576
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
441
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
140
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
89
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
298
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
395